User:Fmoser: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
 
(4 intermediate revisions by the same user not shown)
Line 6: Line 6:
== Bio: ==
== Bio: ==


PhD Graduate Student, UCSF-UCB Joint Graduate Group in Bioengineering
Postdoc, [http://web.mit.edu/voigtlab/ Voigt Group], MIT Bioengineering.


Grew up in Furstenfeldbruck, Germany and Wichita Falls, TX.
PhD in Bioengineering from MIT, 2013.


BA Cornell University 2007 in Biology and Chemistry, with concentration in Biochemistry (go figure).
MS in Bioengineering from UCSF/UCB, 2011.
 
BA in Biology and Chemistry, Magna Cum Lauda, Cornell University, 2007.


Former Endy Lab Tech.
Former Endy Lab Tech.


[http://www.epernicus.com/fm My epernicus profile.]
Grew up in  Germany and Wichita Falls, TX.


== Work: ==
[http://www.linkedin.com/pub/felix-moser/40/8a7/128/ LinkedIn Profile]


== Interests ==


===Endy Lab===
I'm interested in applying biotechnology to solving problems and creating value.


[[Refactoring M13]]
Specifically, I'm most interested in applications of synthetic biology tools to industrial biotechnology, materials, and therapeutics.


Inverter standard
==Publications==


[[IGEM:MIT/2008 |Advising the 2008 MIT iGEM team]]
1) '''Moser, F.''', Horwitz, A., Chen, J., Lim, W.A., and C.A. Voigt (2013). A genetic sensor for strong methylating compounds. ACS Synthetic Biology 2(10), 614-624.


Work for Francois St. Pierre: 1) Recombineering of phage lambda for Aam19 amber mutations, fluorescent reporters of infection; 2) Building fluorescent reporter constructs for N, Q, and CII activities in phage lambda.
2)  '''Moser, F.''', Broers, N.J., Hartmans, S., Tamsir, S., Kerkman, R., Roubos, J.A., Bovenberg, R., and C.A. Voigt (2012). Genetic Circuit Performance under Conditions Relevant for Industrial Bioreactors. ACS Synthetic Biology 1(11), 555-564.  


Work for [[Barry Canton]]: 1) Quantitative analysis of orthogonal vs WT rRNA abundances by quantitative northern blotting; 2) Construction of toxic gene expression systems as a demo for VM utility.
3) Ghosh, D., Kohli, A.G., '''Moser, F.''', Endy, D., and A.M. Belcher (2012). Refactored M13 Bacteriophage as a Platform for Tumor Cell Imaging and Drug Delivery. ACS Synthetic Biology 1(12), 576-582.  


==Publications==
4) Temme, K., Hill, R., Segall-Shapiro, T.H., '''Moser, F.''', and C.A. Voigt (2012). Modular control of multiple pathways using engineered orthogonal T7 polymerases. Nuc. Acids Res. 40(17), 1-9.


Felix Moser, Irwin D, Chen S, Wilson DB. 2008. "Regulation and characterization of Thermobifida fusca carbohydrate-binding module proteins E7 and E8." ''Biotechnology and bioengineering.'' Aug 15;100(6):1066-77
5) '''Moser, F.''', Irwin, D., Chen, S., and D. B. Wilson (2007). Regulation and Characterization of Thermobifida fusca Carbohydrate Binding Domain Proteins E7 and E8. Biotech. & Bioeng. 100 (6), 1066-1077.


Yang Y, Zhang S, Howe K, Wilson DB, Felix Moser, Irwin D, Thannhauser TW. 2007. "A comparison of nLC-ESI-MS/MS and nLC-MALDI-MS/MS for GeLC-based protein identification and iTRAQ-based shotgun quantitative proteomics." ''Journal of biomolecular techniques'' Sep;18(4):226-37.
6) Yang, Y., Zhang, S., Howe, K., Wilson, D.B., '''Moser, F.''', Irwin, D., and T.W. Thannenhauser (2007). A Comparison of nLC-ESI-MS/MS and nLC-MALDI-MS/MS for GeLC-based Protein Identification and iTRAQ-based Shotgun Quantitative Proteomics. J. Biomolecular Techniques 18, 226-237.


== Contact: ==
== Contact: ==


 
fmoser (at) mit (dot) edu
fmoser76@gmail.com
 
c: 607-280-4753

Latest revision as of 10:00, 16 April 2014

Felix Moser

Bio:

Postdoc, Voigt Group, MIT Bioengineering.

PhD in Bioengineering from MIT, 2013.

MS in Bioengineering from UCSF/UCB, 2011.

BA in Biology and Chemistry, Magna Cum Lauda, Cornell University, 2007.

Former Endy Lab Tech.

Grew up in Germany and Wichita Falls, TX.

LinkedIn Profile

Interests

I'm interested in applying biotechnology to solving problems and creating value.

Specifically, I'm most interested in applications of synthetic biology tools to industrial biotechnology, materials, and therapeutics.

Publications

1) Moser, F., Horwitz, A., Chen, J., Lim, W.A., and C.A. Voigt (2013). A genetic sensor for strong methylating compounds. ACS Synthetic Biology 2(10), 614-624.

2) Moser, F., Broers, N.J., Hartmans, S., Tamsir, S., Kerkman, R., Roubos, J.A., Bovenberg, R., and C.A. Voigt (2012). Genetic Circuit Performance under Conditions Relevant for Industrial Bioreactors. ACS Synthetic Biology 1(11), 555-564.

3) Ghosh, D., Kohli, A.G., Moser, F., Endy, D., and A.M. Belcher (2012). Refactored M13 Bacteriophage as a Platform for Tumor Cell Imaging and Drug Delivery. ACS Synthetic Biology 1(12), 576-582.

4) Temme, K., Hill, R., Segall-Shapiro, T.H., Moser, F., and C.A. Voigt (2012). Modular control of multiple pathways using engineered orthogonal T7 polymerases. Nuc. Acids Res. 40(17), 1-9.

5) Moser, F., Irwin, D., Chen, S., and D. B. Wilson (2007). Regulation and Characterization of Thermobifida fusca Carbohydrate Binding Domain Proteins E7 and E8. Biotech. & Bioeng. 100 (6), 1066-1077.

6) Yang, Y., Zhang, S., Howe, K., Wilson, D.B., Moser, F., Irwin, D., and T.W. Thannenhauser (2007). A Comparison of nLC-ESI-MS/MS and nLC-MALDI-MS/MS for GeLC-based Protein Identification and iTRAQ-based Shotgun Quantitative Proteomics. J. Biomolecular Techniques 18, 226-237.

Contact:

fmoser (at) mit (dot) edu